Didactics – UCLA-Olive View Internal Medicine

Feb 14 2020

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (AFIRE)

EBM, Journal Club

Presented by Dr. Nikita Jambulingam

Moderated by Dr. Matthew McCullough

Thank you Nikita for leading us through a discussion of the AFIRE trial.

Clinical Question:

In patients with atrial fibrillation and stable CAD >1 year after revascularization (or confirmed CAD on angiography not requiring revascularization), how does rivaroxaban monotherapy compare to rivaroxaban plus an antiplatelet agent in terms of efficacy and safety?

Clinical Topics:

Cardiology

Jul 01 2019

Strategies for Multivessel Revascularization in Patients with Diabetes (FREEDOM)

EBM, Landmark Research

What treatment is recommend for diabetic patients with 3-vessel coronary artery disease? Review this landmark article to find the evidence for multivessel CAD treatment recommendations in diabetes.

Clinical Topics:

Cardiology

Aug 01 2017

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction (EPHESUS Trial)

EBM, Landmark Research

Clinical Topics:

Aug 01 2017

Optimal Medical Therapy with or without PCI for Stable Coronary Disease (COURAGE Trial)

EBM, Landmark Research

Clinical Topics:

Archive of Didactics in CAD

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (AFIRE)

Clinical Question:

Clinical Topics:

Strategies for Multivessel Revascularization in Patients with Diabetes (FREEDOM)

Clinical Topics:

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction (EPHESUS Trial)

Clinical Topics:

Optimal Medical Therapy with or without PCI for Stable Coronary Disease (COURAGE Trial)

Clinical Topics:

Medical School

Residency

Fellowship